CpG-coated Prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma.

Authors

Juliana Cano-Mejia, George Washington University
Anshi Shukla, George Washington University
Debbie K. Ledezma, George Washington University
Erica Palmer, George Washington University
Alejandro Villagra, George Washington University
Rohan Fernandes, George Washington University

Document Type

Journal Article

Publication Date

7-8-2020

Journal

Translational Oncology

Volume

13

Issue

10

DOI

10.1016/j.tranon.2020.100823

Comments

Online ahead of print

APA Citation

Cano-Mejia, J., Shukla, A., Ledezma, D. K., Palmer, E., Villagra, A., & Fernandes, R. (2020). CpG-coated Prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma.. Translational Oncology, 13 (10). http://dx.doi.org/10.1016/j.tranon.2020.100823

Peer Reviewed

1

Open Access

1